Literature DB >> 29388098

Expression of Exogenous Genes in Murine Primary B Cells and B Cell Lines Using Retroviral Vectors.

Zhiyong Yang1,2, Christopher D C Allen3,4,5.   

Abstract

B cells, after activation, can undergo class-switch recombination and somatic hypermutation of their immunoglobulin genes, and can differentiate into memory cells and plasma cells. Expressing genes in altered versions in primary B cells and B cell lines is an important approach to understanding how B cell receptor signaling leads to B cell activation and differentiation. Recombinant retrovirus-based transduction is the most efficient method to deliver exogenous genes for expression in B cells. In this chapter, we describe streamlined protocols for using recombinant retroviral vectors to transduce both murine primary B cells and B cell lines.

Entities:  

Keywords:  B cell lines; Exogenous gene expression; Primary B cell; Retroviral vector; Spinfection; Transduction

Mesh:

Substances:

Year:  2018        PMID: 29388098      PMCID: PMC6675621          DOI: 10.1007/978-1-4939-7474-0_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

1.  Introduction of genes into primary murine splenic B cells using retrovirus vectors.

Authors:  Kuo-I Lin; Kathryn Calame
Journal:  Methods Mol Biol       Date:  2004

2.  An improved cyan fluorescent protein variant useful for FRET.

Authors:  Mark A Rizzo; Gerald H Springer; Butch Granada; David W Piston
Journal:  Nat Biotechnol       Date:  2004-02-29       Impact factor: 54.908

3.  Design and construction of 2A peptide-linked multicistronic vectors.

Authors:  Andrea L Szymczak-Workman; Kate M Vignali; Dario A A Vignali
Journal:  Cold Spring Harb Protoc       Date:  2012-02-01

4.  General principles of retrovirus vector design.

Authors:  Tammy Chang; Jiing-Kuan Yee
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

5.  Fluorescent in vivo detection reveals that IgE(+) B cells are restrained by an intrinsic cell fate predisposition.

Authors:  Zhiyong Yang; Brandon M Sullivan; Christopher D C Allen
Journal:  Immunity       Date:  2012-03-08       Impact factor: 31.745

6.  Generation of high-titer, helper-free retroviruses by transient transfection.

Authors:  W S Pear; M L Scott; G P Nolan
Journal:  Methods Mol Med       Date:  1997

7.  Rapid and efficient retrovirus-mediated gene transfer into B cell lines.

Authors:  D L Krebs; Y Yang; M Dang; J Haussmann; M R Gold
Journal:  Methods Cell Sci       Date:  1999

8.  High Efficiency Ex Vivo Gene Transfer to Primary Murine B Cells Using Plasmid or Viral Vectors.

Authors:  Babak Moghimi; Irene Zolotukhin; Brandon K Sack; Roland W Herzog; Ou Cao
Journal:  J Genet Syndr Gene Ther       Date:  2011-03-15

9.  The scaffolding protein synapse-associated protein 97 is required for enhanced signaling through isotype-switched IgG memory B cell receptors.

Authors:  Wanli Liu; Elizabeth Chen; Xing Wang Zhao; Zheng Peng Wan; Yi Ren Gao; Angel Davey; Eric Huang; Lijia Zhang; Jillian Crocetti; Gabriel Sandoval; M Gordon Joyce; Carrie Miceli; Jan Lukszo; L Aravind; Wojciech Swat; Joseph Brzostowski; Susan K Pierce
Journal:  Sci Signal       Date:  2012-07-31       Impact factor: 8.192

10.  Proteasome inhibitors disrupt the unfolded protein response in myeloma cells.

Authors:  Ann-Hwee Lee; Neal N Iwakoshi; Kenneth C Anderson; Laurie H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-05       Impact factor: 11.205

View more
  2 in total

1.  CD97 promotes spleen dendritic cell homeostasis through the mechanosensing of red blood cells.

Authors:  Dan Liu; Lihui Duan; Lauren B Rodda; Erick Lu; Ying Xu; Jinping An; Longhui Qiu; Fengchun Liu; Mark R Looney; Zhiyong Yang; Christopher D C Allen; Zhongmei Li; Alexander Marson; Jason G Cyster
Journal:  Science       Date:  2022-02-11       Impact factor: 63.714

2.  A System Based on Novel Parainfluenza Virus PIV5-L for Efficient Gene Delivery of B-Lymphoma Cells.

Authors:  Xiaoqing Liu; Lilan Zheng; Ting Wang; Ying Li; Bingbing Wu; Shujuan Du; Qing Zhu; Caixia Zhu; Yuyan Wang; Rong Zhang; Fang Wei; Qiliang Cai
Journal:  J Virol       Date:  2022-04-04       Impact factor: 6.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.